DK1383507T3 - Anvendelse af galanthamin til behandling af sygdomssymptomer i det centrale nervesystem på grund af intoxikationer med psykotrope substanser - Google Patents
Anvendelse af galanthamin til behandling af sygdomssymptomer i det centrale nervesystem på grund af intoxikationer med psykotrope substanserInfo
- Publication number
- DK1383507T3 DK1383507T3 DK02764017T DK02764017T DK1383507T3 DK 1383507 T3 DK1383507 T3 DK 1383507T3 DK 02764017 T DK02764017 T DK 02764017T DK 02764017 T DK02764017 T DK 02764017T DK 1383507 T3 DK1383507 T3 DK 1383507T3
- Authority
- DK
- Denmark
- Prior art keywords
- intoxications
- galanthamine
- treatment
- nervous system
- central nervous
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Addiction (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10119862A DE10119862A1 (de) | 2001-04-24 | 2001-04-24 | Verwendung von Galanthamin zur Behandlung von Krankheitserscheinungen des zentralen Nervensystems aufgrund von Intoxikationen mit psychotropen Substanzen |
PCT/EP2002/004277 WO2002085370A1 (de) | 2001-04-24 | 2002-04-18 | Verwendung von galanthamin zur behandlung von krankheitserscheinungen des zentralen nervensystems aufgrund von intoxikationen mit psychotropen substanzen |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1383507T3 true DK1383507T3 (da) | 2008-03-17 |
Family
ID=7682409
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK02764017T DK1383507T3 (da) | 2001-04-24 | 2002-04-18 | Anvendelse af galanthamin til behandling af sygdomssymptomer i det centrale nervesystem på grund af intoxikationer med psykotrope substanser |
Country Status (27)
Country | Link |
---|---|
US (1) | US8207159B2 (da) |
EP (1) | EP1383507B1 (da) |
JP (1) | JP2004531533A (da) |
KR (1) | KR20040005934A (da) |
CN (1) | CN100400043C (da) |
AR (1) | AR033468A1 (da) |
AT (1) | ATE378052T1 (da) |
AU (1) | AU2002308148B2 (da) |
BR (1) | BR0209126A (da) |
CA (1) | CA2444818C (da) |
CZ (1) | CZ20032789A3 (da) |
DE (2) | DE10119862A1 (da) |
DK (1) | DK1383507T3 (da) |
EA (1) | EA200301135A1 (da) |
ES (1) | ES2296990T3 (da) |
HK (1) | HK1062401A1 (da) |
HU (1) | HUP0401123A3 (da) |
IL (2) | IL158382A0 (da) |
MX (1) | MXPA03009765A (da) |
NO (1) | NO20034740L (da) |
NZ (1) | NZ529004A (da) |
PL (1) | PL207525B1 (da) |
PT (1) | PT1383507E (da) |
SK (1) | SK287235B6 (da) |
TW (1) | TWI329512B (da) |
WO (1) | WO2002085370A1 (da) |
ZA (1) | ZA200308004B (da) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2516618A1 (en) * | 2003-02-27 | 2004-09-10 | Shirankai Kyoto University Faculty Of Medicine Alumni Association Inc. | Pharmaceutical composition for treatment of drug dependence |
DE10338544B4 (de) * | 2003-08-19 | 2017-08-31 | Janssen Pharmaceutica N.V. | Buccale Formulierungen des Galanthamins und deren Anwendungen |
FR2930891B1 (fr) | 2008-05-06 | 2010-09-24 | Biocodex | Composes anti-amnesiants et compositions pharmaceutiques les comprenant |
EP2586436A1 (en) * | 2011-10-31 | 2013-05-01 | Commissariat à l'Énergie Atomique et aux Énergies Alternatives | Use of anti-connexin agents for enhancing the therapeutic effect of acetylcholinesterase inhibitor |
WO2016187339A1 (en) * | 2015-05-18 | 2016-11-24 | Synaptec Development Llc | GALANTAMINE CLEARANCE OF AMYLOIDß |
US20230202978A1 (en) | 2022-03-04 | 2023-06-29 | Reset Pharmaceuticals, Inc. | Co-crystal or salt |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1193061B (de) | 1961-12-20 | 1965-05-20 | Vni Chimiko Pharmazewtitschesk | Verfahren zur Gewinnung von Galanthamin-hydrobromid aus Pflanzen der Familie der Amaryllidaceen |
US3797494A (en) | 1969-04-01 | 1974-03-19 | Alza Corp | Bandage for the administration of drug by controlled metering through microporous materials |
US3996934A (en) | 1971-08-09 | 1976-12-14 | Alza Corporation | Medical bandage |
US3742951A (en) | 1971-08-09 | 1973-07-03 | Alza Corp | Bandage for controlled release of vasodilators |
US4031894A (en) | 1975-12-08 | 1977-06-28 | Alza Corporation | Bandage for transdermally administering scopolamine to prevent nausea |
DE3315272C2 (de) | 1983-04-27 | 1986-03-27 | Lohmann Gmbh & Co Kg, 5450 Neuwied | Pharmazeutisches Produkt und Verfahren zu seiner Herstellung |
US4666829A (en) * | 1985-05-15 | 1987-05-19 | University Of California | Polypeptide marker for Alzheimer's disease and its use for diagnosis |
US6150354A (en) * | 1987-01-15 | 2000-11-21 | Bonnie Davis | Compounds for the treatment of Alzheimer's disease |
DE3843239C1 (da) | 1988-12-22 | 1990-02-22 | Lohmann Therapie Syst Lts | |
US5015645A (en) * | 1989-10-19 | 1991-05-14 | Ciba-Geigy Corporation | Tetracyclic pyrrole lactam derivatives |
US5519017A (en) | 1990-03-29 | 1996-05-21 | Lts Lohmann Therapie-Systeme Gmbh + Co. Kg | Pharmaceutic formulation for the treatment of alcoholism |
DE4010079A1 (de) * | 1990-03-29 | 1991-10-02 | Lohmann Therapie Syst Lts | Pharmazeutische formulierung zur behandlung des alkoholismus |
US5336675A (en) * | 1991-05-14 | 1994-08-09 | Ernir Snorrason | Method of treating mania in humans |
DE4301782C1 (de) * | 1993-01-23 | 1994-08-25 | Lohmann Therapie Syst Lts | Verwendung von Galanthamin zur Behandlung der Nicotinabhängigkeit |
DE19509663A1 (de) | 1995-03-17 | 1996-09-19 | Lohmann Therapie Syst Lts | Verfahren zur Isolierung von Galanthamin |
AU4078997A (en) * | 1996-08-22 | 1998-03-06 | New York University | Cholinesterase inhibitors for treatment of parkinson's disease |
US5932557A (en) * | 1997-08-12 | 1999-08-03 | Mustafa; S. Jamal | Adenosine A1 receptor antisense oligonucleotide treatment of alcohol and marijuana-induced psychomotor impairments |
EP1231877A4 (en) * | 1999-11-04 | 2009-03-18 | Xel Herbaceuticals | TRANSDERMALE ADMINISTRATION OF HUPERZIN |
US20020151591A1 (en) * | 2000-10-17 | 2002-10-17 | Anabella Villalobos | Combination use of acetylcholinesterase inhibitors and GABAa inverse agonists for the treatment of cognitive disorders |
-
2001
- 2001-04-24 DE DE10119862A patent/DE10119862A1/de not_active Withdrawn
-
2002
- 2002-04-18 PL PL366840A patent/PL207525B1/pl not_active IP Right Cessation
- 2002-04-18 US US10/475,357 patent/US8207159B2/en not_active Expired - Fee Related
- 2002-04-18 EA EA200301135A patent/EA200301135A1/ru unknown
- 2002-04-18 HU HU0401123A patent/HUP0401123A3/hu unknown
- 2002-04-18 MX MXPA03009765A patent/MXPA03009765A/es active IP Right Grant
- 2002-04-18 ES ES02764017T patent/ES2296990T3/es not_active Expired - Lifetime
- 2002-04-18 EP EP02764017A patent/EP1383507B1/de not_active Expired - Lifetime
- 2002-04-18 SK SK1315-2003A patent/SK287235B6/sk not_active IP Right Cessation
- 2002-04-18 NZ NZ529004A patent/NZ529004A/en unknown
- 2002-04-18 CA CA002444818A patent/CA2444818C/en not_active Expired - Lifetime
- 2002-04-18 PT PT02764017T patent/PT1383507E/pt unknown
- 2002-04-18 KR KR10-2003-7013971A patent/KR20040005934A/ko active Search and Examination
- 2002-04-18 AT AT02764017T patent/ATE378052T1/de active
- 2002-04-18 AU AU2002308148A patent/AU2002308148B2/en not_active Ceased
- 2002-04-18 BR BR0209126-7A patent/BR0209126A/pt not_active Application Discontinuation
- 2002-04-18 DE DE50211207T patent/DE50211207D1/de not_active Expired - Lifetime
- 2002-04-18 CN CNB028088905A patent/CN100400043C/zh not_active Expired - Lifetime
- 2002-04-18 WO PCT/EP2002/004277 patent/WO2002085370A1/de active IP Right Grant
- 2002-04-18 JP JP2002582943A patent/JP2004531533A/ja active Pending
- 2002-04-18 DK DK02764017T patent/DK1383507T3/da active
- 2002-04-18 IL IL15838202A patent/IL158382A0/xx unknown
- 2002-04-18 CZ CZ20032789A patent/CZ20032789A3/cs unknown
- 2002-04-22 TW TW091108204A patent/TWI329512B/zh not_active IP Right Cessation
- 2002-04-24 AR ARP020101482A patent/AR033468A1/es unknown
-
2003
- 2003-10-13 IL IL158382A patent/IL158382A/en active IP Right Grant
- 2003-10-15 ZA ZA200308004A patent/ZA200308004B/en unknown
- 2003-10-23 NO NO20034740A patent/NO20034740L/no not_active Application Discontinuation
-
2004
- 2004-07-02 HK HK04104742A patent/HK1062401A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1572215T3 (da) | Benzo[D]azepin-derivater til behandling af neurologiske lidelser | |
DK1474416T3 (da) | Dihydrobenzodiazepin-2-on-derivater til behandlingen af neurologiske lidelser | |
DK1656347T3 (da) | Substituerede indolderivater til farmaceutisk sammensætning til behandling af luftvejssygdomme | |
DK1339406T3 (da) | Piperazinderivater, fremgangsmåde til fremstilling deraf og anvendelse deraf til behandling af lidelser i centralnervesystemet | |
DK1562932T3 (da) | 4 tetrazolyl-4-phenylpiperidinderivater til behandling af smerter | |
DK1425001T3 (da) | Phenethanolaminderivater til behandling af respiratoriske sygdomme | |
DK1343773T3 (da) | Thiazolderivater til behandling af PPAR-beslægtede forstyrrelser | |
DE60317887D1 (de) | System zur verabreichung therapeutischer substanzen | |
DK1282616T3 (da) | Hydroxyphenylpiperidin-4-ylidenmethylbenzamidderivater til behandling af smerter | |
DK1841433T3 (da) | Præparat til behandling af lidelser i centralnervesystemet | |
DE60208221D1 (de) | Heterozyklische verbindungen zur behandlung von harnwegserkrankungen | |
DK1491212T3 (da) | Middel til behandling af søvnforstyrrelser | |
NO20034864D0 (no) | Preparat for behandling av legemiddelindusert forstoppelse med 15-keto-prostaglandiner | |
DK1667967T3 (da) | Fremgangsmåde til fremstilling af 2-oxo-1-pyrrolidin-derivater | |
DK1200081T3 (da) | Anvendelse af escitalopram til behandling af generaliseret angstlidelse | |
DE50305374D1 (de) | Neue prodrugs von 1-methyl-2-(4-amidinophenylaminomethyl)-benzimidazol-5-yl-carbonsäure-(n -2-pyridil-n-2-hydroxycarbonylethyl)-amid, ihre herstellung und ihre verwendung als arzneimittel | |
DK1458386T3 (da) | Aroylpyrrolheteroaryl- og methanolforbindelser til behandling af en lidelse i centralnervesystemet | |
DK1344526T3 (da) | Midler til forebyggelse/behandling af inflammatoriske luftvejslidelser | |
DK1383507T3 (da) | Anvendelse af galanthamin til behandling af sygdomssymptomer i det centrale nervesystem på grund af intoxikationer med psykotrope substanser | |
DK1257278T3 (da) | Anvendelse af mirtazapin til behandling af sövnforstyrrelser | |
DK1309322T3 (da) | Anvendelse af 3-benzoylphenyleddikesyrederivater til behandling af retinale lidelser | |
DK1656365T3 (da) | Fremgangsmåde til fremstilling af enantiomerisk rent mirtazapin | |
NO20032156D0 (no) | Behandling av angstforstyrrelser | |
DK1351697T3 (da) | Lægemiddel til fremme af regenerationen af væv | |
AU2002308148A1 (en) | Utilization of galanthamine for the treatment of pathologies of the central nervous system owing to intoxications with psychotropic substances |